Results 211 to 220 of about 13,623 (265)
Some of the next articles are maybe not open access.

Related searches:

Synthetic Cannabinoids

2023
New synthetic cannabinoid agonists have been synthesized during the last decades and promoted for their psychoactive effects, mimicking those of delta-9-tetrahydrocannabinol. These newest cannabimimetic drugs show binding affinities for the cannabinoid CB1 and/or the CB2 receptors.
Fattore, Liana, Marti, Matteo
openaire   +2 more sources

Synthetic Cannabinoids

The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills   +2 more
openaire   +2 more sources

Focus on cannabinoids and synthetic cannabinoids

Clinical Pharmacology & Therapeutics, 2016
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the endocannabinoid system is involved in many physiological processes that are increasingly explored.
R, Le Boisselier   +3 more
openaire   +2 more sources

Regulation of synthetic cannabinoids

The Lancet, 2009
www.thelancet.com Vol 374 November 7, 2009 1595 5 Fuccio L, Zagari RM, Minardi ME, et al. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25: 133–41. As Greta McLachlan reports, the UK Advisory Council for the Misuse of Drugs (ACMD) and the European Monitoring Centre for Drugs and ...
C Heather, Ashton, P Brian, Moore
openaire   +4 more sources

Synthetic cannabinoids revealing adrenoleukodystrophy

Journal of Clinical Neuroscience, 2016
We report a 41-year-old man who presented with a first generalized tonic-clonic seizure after recent consumption of a synthetic cannabinoid. MRI showed extensive bilateral, mainly frontal, white matter lesions. Blood analysis for very long chain fatty acids was compatible with adrenoleukodystrophy, and a missense mutation in the ABCD1 gene confirmed ...
Avi, Fellner   +2 more
openaire   +2 more sources

Nonpsychotropic Synthetic Cannabinoids

Current Pharmaceutical Design, 2000
Unlike natural cannabinoids which belong to the 6aR - trans series, the synthetic dexanabinol (HU-211), a 6aS-trans enantiomer, does not have affinity toward cannabinoid receptors and is devoid of cannabimimetic activity. On the other hand, dexanabinol demonstrated significant neuroprotective properties which prompted its development as a therapeutic ...
openaire   +2 more sources

The Synthetic Cannabinoids Phenomenon

Current Pharmaceutical Design, 2017
« Spice » is generally used to describe the diverse types of herbal blends that encompass synthetic cannabinoids on the market. The emergence of smokable herbal products containing synthetic cannabinoids, which mimic the effects of cannabis, appears to become increasingly popular, in the new psychoactive substances landscape.
Karila, Laurent   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy